Stocks and Investing Stocks and Investing
Fri, February 25, 2022
[ 12:00 AM ] - United States, WOPRAI
John Walsh Maintained (ANSS) at Buy with Decreased Target to $389 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Weston Twigg Maintained (ADSK) at Buy with Decreased Target to $298 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Jason Celino Maintained (ADSK) at Buy with Decreased Target to $260 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Tyler Radke Maintained (ADSK) at Strong Buy with Decreased Target to $286 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Blair Abernethy Maintained (ADSK) at Strong Buy with Decreased Target to $300 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Keith Weiss Maintained (ADSK) at Hold with Decreased Target to $258 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Johannes Schaller Maintained (ADSK) at Strong Buy with Decreased Target to $275 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
James Thalacker Maintained (AEP) at Buy with Decreased Target to $94 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Dana Telsey Maintained (BURL) at Buy with Decreased Target to $300 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Shyam Patil Maintained (BKNG) at Buy on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Brian Gong Maintained (ATHM) at Hold with Decreased Target to $30 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Ryan Koontz Maintained (BAND) at Strong Buy with Decreased Target to $45 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Alicia Yap Maintained (BABA) at Strong Buy with Decreased Target to $200 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Scott Devitt Maintained (BABA) at Strong Buy with Decreased Target to $135 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Eddie Leung Maintained (BABA) at Strong Buy with Decreased Target to $193 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Jerry Liu Maintained (BABA) at Strong Buy with Decreased Target to $150 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Gary Yu Maintained (BABA) at Buy with Decreased Target to $145 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Scott Berg Maintained (AXON) at Strong Buy with Decreased Target to $170 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Paul Chung Upgraded (AXON) to Buy and Decreased Target to $192 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
David Lewis Maintained (AXNX) at Buy with Decreased Target to $69 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Danielle Antalffy Maintained (AXNX) at Buy with Increased Target to $65 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
John Baumgartner Maintained (BYND) at Hold with Decreased Target to $45 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Michael Lavery Maintained (BYND) at Hold with Decreased Target to $50 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Ken Goldman Maintained (BYND) at Sell with Decreased Target to $32 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Bobby Burleson Maintained (BYND) at Hold with Decreased Target to $50 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Chris Pierce Maintained (CARG) at Strong Buy with Increased Target to $52 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Adam Tindle Maintained (ALRM) at Strong Buy with Decreased Target to $85 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Curt Woodworth Maintained (AMBP) at Buy with Decreased Target to $12 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Matt Borsch Upgraded (AMED) to Buy and Held Target at $190 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Michael Wiederhorn Maintained (AMED) at Buy with Decreased Target to $200 on, Feb 25th, 2022

Michael Wiederhorn Maintained (AMED) at Buy with Decreased Target to $200 on, Feb 25th, 2022


Published on 2024-10-27 19:50:00 - WOPRAI, Michael Wiederhorn
  Print publication without navigation


Michael Wiederhorn of Oppenheimer, Maintained "Amedisys, Inc." (AMED) at Buy with Decreased Target from $225 to $200 on, Feb 25th, 2022.

Michael has made no other calls on AMED in the last 4 months.



There are 7 other peers that have a rating on AMED. Out of the 7 peers that are also analyzing AMED, 2 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Whit Mayo of "SVB Leerink" Maintained at Hold with Increased Target to $147 on, Friday, February 18th, 2022
  • Scott Fidel of "Stephens & Co." Maintained at Hold with Increased Target to $185 on, Thursday, November 4th, 2021


These are the ratings of the 5 analyists that currently disagree with Michael

  • Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $175 on, Thursday, February 24th, 2022
  • Steve Valiquette of "Barclays" Maintained at Buy with Decreased Target to $213 on, Tuesday, December 21st, 2021
  • John Ransom of "Raymond James" Maintained at Buy with Decreased Target to $225 on, Monday, November 8th, 2021
  • Jonathan Yong of "Credit Suisse" Maintained at Buy with Increased Target to $205 on, Thursday, November 4th, 2021
  • Frank Morgan of "RBC Capital" Maintained at Buy with Decreased Target to $221 on, Thursday, November 4th, 2021

Contributing Sources